- University Homepage
- About
- Edinburgh Global
- Research
- Projects and experts
- Regenerative medicine
Regenerative medicine - Prof Sir Ian Wilmut
Prof Ian Wilmut’s research achievements are many, but he is most widely known as the leader of the team that produced Dolly the sheep, the first clone of an adult animal.
His many awards include the prestigious 2005 Paul Ehrlich prize, Germany’s top medical research award.
As Director of the Scottish Centre for Regenerative Medicine (SCRM), he and his team bring skills in nuclear transfer to bear on new approaches towards human diseases such as diabetes and neurodegenerative diseases.
The SCRM brings together world-leading basic stem cell research and established clinical excellence to deliver a "bench-to-bedside" approach in addressing the challenges posed by degenerative diseases. Current stem cell research is aimed at developing new treatments for major diseases.
In early 2009 Prof Wilmut forged a strategic link with China's National Centre for International Research in Stem Cells (NCIR).
Through collaboration, Scotland can provide NCIR with access to world-class research, a skilled workforce and a bustling academic research community that is breaking new ground in stem cell biology every day.
Prof Ian Wilmut
as quoted in The Scotsman
Over the past year Prof Wilmut and other University of Edinburgh researchers have made key discoveries which could:
- help reduce the need for liver transplants
- produce synthetic blood to guarantee a supply for transfusions
- mend shattered bones
- screen for harmful side effects before new drugs are trialled
This article was published on Jun 14, 2010